Status:
WITHDRAWN
A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Iron Deficiency
Eligibility:
All Genders
7-70 years
Phase:
PHASE4
Brief Summary
This is a pilot study designed to compare the tolerance of ionic iron (ferrous sulphate) with heme iron polypeptide. Subjects will take one week of one product followed by a week with no product follo...
Detailed Description
Iron deficiency anemia (IDA) is a worldwide problem in both children and adults. Traditional ionic oral iron supplements have many disadvantages including high gastrointestinal side effects, poor and ...
Eligibility Criteria
Inclusion
- able to fill out daily diary
Exclusion
- known iron overload
- sensitivity to either product used
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01865175
Start Date
January 1 2016
End Date
May 1 2016
Last Update
September 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hershey Medical Center
Hershey, Pennsylvania, United States, 17033